Evidence map›Paper›PMID 42308117›Full record

ArticleChemSusChem2026

Tailoring Co-Catalysts in Pd Quantum-Dots-Functionalized BiFeO

Wenying Le, Jiale Zhou, Weirang Xu, Wei Qiu, Wangying Xu, Qiubao Lin, Xiaowei Chen, Weicheng Huang, Danqing Liu

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in ChemSusChem, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Wenying LeDepartment of Physics, School of Science, Jimei University, Xiamen, China.
Jiale ZhouDepartment of Physics, School of Science, Jimei University, Xiamen, China.
Weirang XuDepartment of Physics, School of Science, Jimei University, Xiamen, China.
Wei QiuDepartment of Physics, School of Science, Jimei University, Xiamen, China.
Wangying XuDepartment of Physics, School of Science, Jimei University, Xiamen, China.
Qiubao LinDepartment of Physics, School of Science, Jimei University, Xiamen, China.
Xiaowei ChenDepartment of Physics, School of Science, Jimei University, Xiamen, China.
Weicheng HuangDepartment of Physics, School of Science, Jimei University, Xiamen, China.ORCID https://orcid.org/0000-0003-3466-5169
Danqing LiuSchool of Material Science and Chemical Engineering, Key Laboratory of Green Chemical Engineering and Technology of Heilongjiang Province, Harbin University of Science and Technology, Harbin, China.

Funding

Fujian Provincial Natural Science Foundation of China 2022J05158National Natural Science Foundation of China 52172085National Natural Science Foundation of China 52202091Scientific Research Foundation of Jimei University ZQ2022014
6 · The paper itself

Abstract

Piezocatalytic hydrogen evolution holds significant promise for addressing the global energy crisis by converting mechanical energy directly into chemical fuel. However, developing efficient noble-metal quantum-dot-functionalized piezocatalysts and understanding their underlying mechanisms remains challenging. Herein, a specially designed mechanical energy conversion platform based on the co-catalyst-modified Pd quantum-dots-functionalized bismuth ferrite nanorods (Pd-BFO) is constructed via a facile combined electrospinning-chemical reduction method and tailored for unlocking efficient piezocatalytic hydrogen evolution reaction (HER). The optimized Pd-BFO with ultra-low loading of 0.5 wt% Pd quantum dot (Pd-QDs) achieves a superior piezocatalytic hydrogen evolution rate of 4253.44 μmol g

Indexed as

BFO piezocatalystco‐catalystHERPd quantum‐dots

Identifiers

PMID42308117
PMCPMC13369848

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.